Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T, Ogawa T, Takahashi S, Okami K, Fujii T, Tanaka K, Iwae S, Ota I, Ueda T, Monden N, Matsuura K, Kojima H, Ueda S, Sasaki K, Fujimoto Y, Hasegawa Y, Beppu T, Nishimori H, Hirano S, Naka Y, Matsushima Y, Fujii M, Tahara M.
Yokota T, et al. Among authors: fujii m, fujii t.
BMC Cancer. 2017 May 5;17(1):314. doi: 10.1186/s12885-017-3295-4.
BMC Cancer. 2017.
PMID: 28476132
Free PMC article.
Clinical Trial.